Imidazonaphthyridines
US6638944B2 · kind B2 · utility
54Cited by
35References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2002 |
| Grant date | Oct 28, 2003 |
| Priority date | — |
| Expiry date | Jun 27, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Imidazonaphthyridine compounds that have a urea containing substituent at the 1-position induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.